1. Home
  2. KOS vs ABCL Comparison

KOS vs ABCL Comparison

Compare KOS & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOS
  • ABCL
  • Stock Information
  • Founded
  • KOS 2003
  • ABCL 2012
  • Country
  • KOS United States
  • ABCL Canada
  • Employees
  • KOS N/A
  • ABCL N/A
  • Industry
  • KOS Oil & Gas Production
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOS Energy
  • ABCL Health Care
  • Exchange
  • KOS Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • KOS 817.4M
  • ABCL 772.9M
  • IPO Year
  • KOS 2011
  • ABCL 2020
  • Fundamental
  • Price
  • KOS $2.16
  • ABCL $3.41
  • Analyst Decision
  • KOS Buy
  • ABCL Strong Buy
  • Analyst Count
  • KOS 6
  • ABCL 4
  • Target Price
  • KOS $4.52
  • ABCL $8.33
  • AVG Volume (30 Days)
  • KOS 12.8M
  • ABCL 6.1M
  • Earning Date
  • KOS 08-04-2025
  • ABCL 08-05-2025
  • Dividend Yield
  • KOS N/A
  • ABCL N/A
  • EPS Growth
  • KOS N/A
  • ABCL N/A
  • EPS
  • KOS N/A
  • ABCL N/A
  • Revenue
  • KOS $1,546,854,000.00
  • ABCL $23,114,000.00
  • Revenue This Year
  • KOS N/A
  • ABCL N/A
  • Revenue Next Year
  • KOS $12.42
  • ABCL $66.89
  • P/E Ratio
  • KOS N/A
  • ABCL N/A
  • Revenue Growth
  • KOS N/A
  • ABCL N/A
  • 52 Week Low
  • KOS $1.39
  • ABCL $1.89
  • 52 Week High
  • KOS $5.97
  • ABCL $3.68
  • Technical
  • Relative Strength Index (RSI)
  • KOS 61.91
  • ABCL 76.76
  • Support Level
  • KOS $2.09
  • ABCL $3.10
  • Resistance Level
  • KOS $2.32
  • ABCL $3.57
  • Average True Range (ATR)
  • KOS 0.13
  • ABCL 0.25
  • MACD
  • KOS 0.04
  • ABCL 0.10
  • Stochastic Oscillator
  • KOS 74.19
  • ABCL 89.68

About KOS Kosmos Energy Ltd. (DE)

Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: